\u798f\u6cf0\u88fd\u85e5Vertex Pharmaceuticals\uff08NASDAQ:VRTX\uff09<\/a>\u7684CRISPR\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5Casgevy\uff0c\u4ee5\u53caBluebird bio Inc\uff08NASDAQ:BLUE\uff09\u958b\u767c\u7684Lyfgenia\u3002\u6b64\u5916\uff0cEditas Medicine\uff08NASDAQ:EDIT\uff09\u76ee\u524d\u6b63\u5728\u9032\u884c\u5176CRISPR\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5Reni-Cel\u548cEdiTHAL\u7684\u81e8\u5e8a\u8a66\u9a57\u3002Intellia Therapeutics\uff08NASDAQ:NTLA\uff09\u7684\u7814\u767c\u7ba1\u7dda\u4e5f\u5305\u62ec\u591a\u7a2eCRISPR\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u3002<\/p>\n\u5728\u7d44\u7e54\u5de5\u7a0b\u6216\u751f\u7269\u6253\u5370\u4e2d\uff0cCRISPR\u6280\u8853\u9084\u53ef\u7528\u65bc\u4fee\u6539\u7d30\u80de\uff0c\u5275\u9020\u51fa\u7528\u65bc\u79fb\u690d\u7b49\u6cbb\u7642\u76ee\u7684\u7684\u500b\u6027\u5316\u7684\u7d44\u7e54\u548c\u5668\u5b98\u3002\u6700\u8fd1\uff0c\u52a0\u62ff\u5927\u7814\u7a76\u5718\u968a\u958b\u767c\u7684\u4fbf\u651c\u5f0f\u751f\u7269\u6253\u5370\u8a2d\u5099\u53ef\u4ee5\u5728\u4eba\u9ad4\u5167\u6253\u5370\u751f\u7269\u76f8\u5bb9\u7d50\u69cb\u3002<\/p>\n
\u764c\u75c7\u514d\u75ab\u7642\u6cd5<\/h2>\n
\u8fd1\u5e74\u4f86\uff0c\u764c\u75c7\u514d\u75ab\u6cbb\u7642\u9818\u57df\u53d6\u5f97\u4e86\u91cd\u8981\u9032\u5c55\uff0c\u9019\u90e8\u5206\u6b78\u529f\u65bc\u985e\u4f3cCAR-T\u7d30\u80de\u7642\u6cd5\u7b49\u751f\u7269\u6280\u8853\u7684\u9032\u6b65\u3002\u96d6\u7136CAR-T\u7642\u6cd5\u4ecd\u8655\u65bc\u65e9\u671f\u968e\u6bb5\uff0c\u4f46\u5b83\u662f\u764c\u75c7\u514d\u75ab\u6cbb\u7642\u4e2d\u4e00\u500b\u5099\u53d7\u95dc\u6ce8\u7684\u6709\u524d\u9014\u7684\u9818\u57df\u3002BioInformant\u76842024\u5e74CAR-T\u878d\u8cc7\u5831\u544a\u986f\u793a\uff0c\u5728\u904e\u53bb\u768410\u5e74\u88e1\uff0c\u5f9e\u4e8bCAR-T\u7642\u6cd5\u7684\u516c\u53f8\u5171\u5438\u5f15\u4e8667\u5104\u7f8e\u5143\u7684\u98a8\u96aa\u6295\u8cc7\uff0c\u4e26\u901a\u904e\u9996\u6b21\u516c\u958b\u767c\u884c\u7c4c\u96c6\u4e8657.6\u5104\u7f8e\u5143\u3002\u5118\u7ba1FDA\u5df2\u7d93\u6279\u51c6\u4e866\u6b3eCAR-T\u7642\u6cd5\uff0c\u4f46\u98a8\u96aa\u554f\u984c\u662f\u4e00\u500b\u96b1\u6182\u3002<\/p>\n
\u77ed\u671f\u4e4b\u5167\uff0c\u6297\u9ad4\u85e5\u7269\u5076\u806f\u7269\uff08ADCs\uff09\u5c07\u6703\u6709\u66f4\u591a\u7684\u63a2\u7d22\u3002\u6bd4\u5982\u8aaa\uff0c\u7f85\u6c0fRoche\uff08OTCQX:RHHBF, SWX:RO\uff09\u5b50\u516c\u53f8\u57fa\u56e0\u6cf0\u514b\u76ee\u524d\u6b63\u5728\u7814\u7a76\u57fa\u65bc\u6297\u9ad4\u7684\u85e5\u7269tiragolumab\u8207Tecentriq\u806f\u5408\u4f7f\u7528\u6642\u7684\u6709\u6548\u6027\u3002\u5409\u5229\u5fb7\u79d1\u5b78Gilead Sciences\uff08NASDAQ:GILD\uff09\u662f\u53e6\u4e00\u5bb6\u5728\u958b\u767cADC\u7642\u6cd5\u7684\u516c\u53f8\uff0c\u76ee\u524d\u6b63\u5728\u9032\u884c\u80ba\u764c\u7642\u6cd5\u7684III\u671f\u81e8\u5e8a\u8a66\u9a57\u3002<\/p>\n
\u751f\u7269\u79d1\u6280\u5728\u8fb2\u696d\u9818\u57df\u7684\u61c9\u7528<\/h2>\n
2023\u5e7411\u6708\uff0c\u4e16\u754c\u9818\u8896\u9f4a\u805aCOP28\u8a0e\u8ad6\u6c23\u5019\u5371\u6a5f\u548c\u53ef\u6301\u7e8c\u7ce7\u98df\u7cfb\u7d71\u7684\u89e3\u6c7a\u65b9\u6848\uff0c\u4e00\u4e9b\u5c08\u5bb6\u63d0\u51fa\u751f\u7269\u6280\u8853\u53ef\u80fd\u6210\u70ba\u8fb2\u696d\u5275\u65b0\u89e3\u6c7a\u65b9\u6848\u7684\u6f5b\u5728\u4f86\u6e90\u3002\u8f49\u57fa\u56e0\u4f5c\u7269\u5177\u6709\u589e\u52a0\u7522\u91cf\uff0c\u63d0\u9ad8\u71df\u990a\u50f9\u503c\u4ee5\u53ca\u62b5\u6297\u6c23\u5019\u8b8a\u5316\u7684\u6f5b\u529b\uff0c\u6709\u53ef\u80fd\u5728\u89e3\u6c7a\u5168\u7403\u7ce7\u98df\u5371\u6a5f\u4e2d\u626e\u6f14\u91cd\u8981\u89d2\u8272\u3002<\/p>\n
\u751f\u7269\u6280\u8853\u7684\u5275\u65b0\u63a8\u52d5\u4e86\u7cbe\u51c6\u8fb2\u696d\u548c\u7acb\u9ad4\u8fb2\u696d\u7684\u767c\u5c55\uff0c\u7121\u4eba\u6a5f\u548c\u50b3\u611f\u5668\u7b49\u6280\u8853\u7684\u61c9\u7528\u53ef\u4ee5\u512a\u5316\u8fb2\u696d\u7a2e\u690d\uff0c\u6e1b\u5c11\u8fb2\u85e5\u548c\u5316\u80a5\u7684\u4f7f\u7528\u3002\u6b64\u5916\uff0c\u7d30\u80de\u8fb2\u696d\u662f\u751f\u7269\u6280\u8853\u7684\u4e00\u7a2e\u5f62\u5f0f\uff0c\u79d1\u5b78\u5bb6\u5011\u5df2\u7d93\u80fd\u5920\u751f\u7522\u5be6\u9a57\u5ba4\u57f9\u990a\u7684\u8089\u985e\u548c\u4e73\u88fd\u54c1\u3002\u5118\u7ba1\u9084\u8655\u65bc\u65e9\u671f\u968e\u6bb5\uff0c\u4f46\u5b83\u6709\u671b\u6e1b\u8f15\u52d5\u7269\u7522\u54c1\u7684\u9700\u6c42\u7d66\u50b3\u7d71\u8fb2\u5834\u5e36\u4f86\u7684\u58d3\u529b\u3002\u6700\u5f8c\uff0c\u5408\u6210\u751f\u7269\u5b78\u53ef\u4ee5\u61c9\u7528\u4e8e\u5275\u9020\u975e\u751f\u7269\u53ef\u964d\u89e3\u6750\u6599\u7684\u751f\u7269\u66ff\u4ee3\u54c1\uff0c\u4ee5\u53ca\u901a\u904e\u57fa\u56e0\u5de5\u7a0b\u5fae\u751f\u7269\u5354\u52a9\u751f\u7269\u4fee\u5fa9\u3002<\/p>\n
\u5176\u4ed6\u503c\u5f97\u95dc\u6ce8\u7684\u7d93\u6fdf\u56e0\u7d20<\/h2>\n
\u53bb\u5e7411\u6708\u548c12\u6708\uff0c\u751f\u7269\u79d1\u6280\u9818\u57df\u522e\u8d77\u4e26\u8cfc\u98a8\u6f6e\uff0c\u5176\u4e2d12\u6708\u76845\u8d77\u4e26\u8cfc\u70ba\u91ab\u7642\u985e\u57fa\u91d1\u6ce8\u5165300\u5104\u7f8e\u5143\u7684\u8cc7\u91d1\u3002\u53bb\u5e7410\u5927\u751f\u7269\u79d1\u6280\u6295\u8cc7\u4ea4\u6613\u7576\u4e2d\uff0c6\u5b97\u767c\u751f\u5728\u56db\u5b63\u5ea6\uff0c\u5176\u4e2d4\u5b97\u5b8c\u6210\u65bc2023\u5e74\u7684\u6700\u5f8c5\u5468\uff0c\u6700\u53d7\u95dc\u6ce8\u7684\u751f\u7269\u79d1\u6280\u4e26\u8cfc\u5305\u62ec\u827e\u4f2f\u7dadAbbVie\uff08NYSE:ABBV\uff09101\u5104\u7f8e\u5143\u6536\u8cfcImmunogen Inc\uff08NASDAQ:IMGN\uff09\uff0c\u4ee5\u53ca87\u5104\u7f8e\u5143\u6536\u8cfcCerevel Therapeutics\u7684\u8a08\u5283\u3002<\/p>\n
12\u670813\u65e5\uff0c\u7f8e\u806f\u5132\u4e3b\u5e2d\u9b91\u5a01\u723e\u7684\u8b1b\u8a71\u63d0\u5347\u4e862024\u5e74\u964d\u606f\u7684\u9810\u671f\uff0c\u9019\u6216\u8a31\u6fc0\u767c\u4e86\u65b0\u4e00\u8f2a\u7684\u4e26\u8cfc\uff0c\u6bd4\u5982\u8aaa12\u670822\u65e5\u767e\u6642\u7f8e\u65bd\u8cb4\u5bf6Bristol-Myers Squibb\uff08NYSE:BMY\uff09\u5ba3\u4f48140\u5104\u7f8e\u5143\u6536\u8cfcKaruna Therapeutics Inc\uff08NASDAQ:KRTX\uff09\uff0c\u4ee5\u53ca4\u5929\u540eRayzeBio (NASDAQ:RYZB)\u5ba3\u4f4841\u5104\u7f8e\u5143\u7684\u6536\u8cfc\u3002\u7f8e\u806f\u5132\u6703\u8b70\u4ee5\u4f86\u622a\u81f31\u670817\u65e5\uff0cSPDR S&P Biotech ETF\uff08ARCA:XBI\uff09\u4e0a\u6f328.26%\u3002<\/p>\n
\u5c55\u671b2024\u5e74\uff0c\u5b89\u6c38\u62ab\u9732\u7a31\u524d25\u5927\u751f\u7269\u88fd\u85e5\u516c\u53f8\u64c1\u67091.37\u842c\u5104\u7f8e\u5143\u7684\u8cc7\u91d1\u7528\u65bc\u5c0b\u6c42\u589e\u9577\u6a5f\u6703\uff0c\u5f62\u5f0f\u5305\u62ec\u4e26\u8cfc\u53ca\u5176\u4ed6\u6230\u7565\u6295\u8cc7\u3002\u6b64\u5916\uff0c2024\u5e74\u8fc4\u4eca\uff0c\u5df2\u7d93\u67095\u5bb6\u751f\u7269\u79d1\u6280\u516c\u53f8\u5ba3\u4f48IPO\uff0c\u6bd4\u5982\u8aaa\u6700\u8fd1\u7684Kyverna Therapeutics\u3002\u76f8\u6bd42023\u5e74\u5168\u5e74\uff0c\u6574\u500b\u751f\u7269\u79d1\u6280\u9818\u57df\u7684IPO\u6578\u91cf\u53ea\u6709\u53ef\u6190\u768419\u500b\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u96d6\u7136\u904e\u53bb\u4e00\u5e74\u751f\u7269\u79d1\u6280\u80a1\u7968\u8868\u73fe\u4e0d\u4f73\uff0c\u4f46\u9019\u500b\u884c\u696d\u7684\u589e\u9577\u6f5b\u529b\u4e26\u672a\u767c\u751f\u6539\u8b8a\u3002\u6309\u7167Grandview Research\u7684 […]<\/p>\n","protected":false},"author":27,"featured_media":484273,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,927,578,564],"class_list":["post-484275","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-927","tag-578","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/484275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=484275"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/484275\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/484273"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=484275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=484275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=484275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}